<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32592103</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>CYP1A2 rs762551 polymorphism and risk for amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>175</StartPage><EndPage>182</EndPage><MedlinePgn>175-182</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-020-04535-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Genetic variability is considered to confer susceptibility to amyotrophic lateral sclerosis (ALS). Oxidative stress is a significant contributor to ALS-related neurodegeneration, and it is regulated by cytochromes P450 (CYPs), such as CYP1A2; these are responsible for the oxidative metabolism of both exogenous and endogenous substrates in the brain, subsequently impacting ALS. The function of CYP1A2 is largely affected by genetic variability; however, the impact of CYP1A2 polymorphisms in ALS remains underinvestigated.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to examine the possible association of ALS with the CYP1A2 rs762551 polymorphism, which codes for the high inducibility form of the enzyme.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">One hundred and fifty-five patients with sporadic ALS and 155 healthy controls were genotyped for the CYP1A2 rs762551. Statistical testing for the association of CYP1A2 rs762551 with risk for ALS was performed using SNPstats.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The CYP1A2 rs762551 C allele was associated with a decreased risk of ALS development. In the subgroup analysis according to the ALS site of onset, an association between CYP1A2 rs762551 and limb and bulbar onset of ALS was shown. Cox proportional-hazard regression analyses revealed a significant effect of the CYP1A2 rs762551 on the age of onset of ALS.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on our results, a primarily potential link between the CYP1A2 rs762551 polymorphism and ALS risk could exist.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Siokas</LastName><ForeName>Vasileios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, Faculty of Medicine, University Hospital of Larissa, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Karampinis</LastName><ForeName>Emmanouil</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, Faculty of Medicine, University Hospital of Larissa, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aloizou</LastName><ForeName>Athina-Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, Faculty of Medicine, University Hospital of Larissa, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mentis</LastName><ForeName>Alexios-Fotios A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Thessaly, University Hospital of Larissa, Larissa, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Laboratories, Hellenic Pasteur Institute, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liakos</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Biochemistry, Faculty of Medicine, University of Thessaly, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadimitriou</LastName><ForeName>Dimitra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neurological Department, Henry Dunant Hospital Center, 107 Mesogeion Avenue, 11526, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liampas</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, Faculty of Medicine, University Hospital of Larissa, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasios</LastName><ForeName>Grigorios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Speech and Language Therapy, University of Ioannina, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogdanos</LastName><ForeName>Dimitrios P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, University General Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Viopolis, 40500, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadjigeorgiou</LastName><ForeName>Georgios M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, Faculty of Medicine, University Hospital of Larissa, Larissa, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of Cyprus, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dardiotis</LastName><ForeName>Efthimios</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2957-641X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, Faculty of Medicine, University Hospital of Larissa, Larissa, Greece. edar@med.uth.gr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Code: 5287</GrantID><Agency>The study was supported in part by a research grant of the Research Committee of the University of Thessaly, Greece (Code: 5287).</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.14.14.1</RegistryNumber><NameOfSubstance UI="C504573">CYP1A2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.14.1</RegistryNumber><NameOfSubstance UI="D019388">Cytochrome P-450 CYP1A2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019388" MajorTopicYN="Y">Cytochrome P-450 CYP1A2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">CYP1A2</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Polymorphism</Keyword><Keyword MajorTopicYN="N">rs762551</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32592103</ArticleId><ArticleId IdType="doi">10.1007/s10072-020-04535-x</ArticleId><ArticleId IdType="pii">10.1007/s10072-020-04535-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morgan S, Orrell RW (2016) Pathogenesis of amyotrophic lateral sclerosis. Br Med Bull 119(1):87&#x2013;98. https://doi.org/10.1093/bmb/ldw026</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldw026</ArticleId><ArticleId IdType="pubmed">27450455</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelstowska B, Kuzma-Kozakiewicz M (2020) Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 41:1115&#x2013;1124. https://doi.org/10.1007/s10072-019-04201-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04201-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarlarini C, Greco LC, Lizio A, Gerardi F, Sansone VA, Lunetta C (2019) Taste changes in amyotrophic lateral sclerosis and effects on quality of life. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 40(2):399&#x2013;404. https://doi.org/10.1007/s10072-018-3672-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3672-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, Colville S, Heverin M, Mays I, Pal S, Pender N, Pinto-Grau M, Radakovic R, Shaw CE, Stephenson L, Swingler R, Vajda A, Al-Chalabi A, Hardiman O, Abrahams S (2018) ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 91(15):e1370&#x2013;e1380. https://doi.org/10.1212/wnl.0000000000006317</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000006317</ArticleId><ArticleId IdType="pubmed">30209236</ArticleId><ArticleId IdType="pmc">6177274</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E, Messina P, Logroscino G, Beghi E (2014) Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol 75(2):287&#x2013;297. https://doi.org/10.1002/ana.24096</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24096</ArticleId><ArticleId IdType="pubmed">24382602</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindo K, Satake A, Fukao T, Ichinose Y, Takiyama Y (2020) Palpebral ptosis as the initial symptom of amyotrophic lateral sclerosis. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 41(1):211&#x2013;212. https://doi.org/10.1007/s10072-019-04030-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04030-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M, Lo Coco D, Veglianese P, Vallarola A, Giordana MT, Marcon G, Beghi E, Poloni M, Strong MJ, Iyer AM, Aronica E, Bendotti C (2017) Amyotrophic lateral sclerosis, a multisystem pathology: insights into the role of TNFalpha. Mediat Inflamm 2017:2985051&#x2013;2985016. https://doi.org/10.1155/2017/2985051</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/2985051</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Wu Y, Wang Y, Yang H, Du B, Di W, Xu X, Shi X (2020) Cerebrospinal fluid MFG-E8 as a promising biomarker of amyotrophic lateral sclerosis. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol. https://doi.org/10.1007/s10072-020-04416-3</Citation></Reference><Reference><Citation>Wu Y, Yang X, Li X, Wang H, Wang T (2020) Elevated cerebrospinal fluid homocysteine is associated with blood&#x2013;brain barrier disruption in amyotrophic lateral sclerosis patients. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol. https://doi.org/10.1007/s10072-020-04292-x</Citation></Reference><Reference><Citation>Dardiotis E, Siokas V, Sokratous M, Tsouris Z, Michalopoulou A, Andravizou A, Dastamani M, Ralli S, Vinceti M, Tsatsakis A, Hadjigeorgiou GM (2018) Genetic polymorphisms in amyotrophic lateral sclerosis: evidence for implication in detoxification pathways of environmental toxicants. Environ Int 116:122&#x2013;135. https://doi.org/10.1016/j.envint.2018.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2018.04.008</ArticleId><ArticleId IdType="pubmed">29677557</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis E, Aloizou AM, Siokas V, Patrinos GP, Deretzi G, Mitsias P, Aschner M, Tsatsakis A (2018) The role of MicroRNAs in patients with amyotrophic lateral sclerosis. J Mol Neurosci 66(4):617&#x2013;628. https://doi.org/10.1007/s12031-018-1204-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-018-1204-1</ArticleId><ArticleId IdType="pubmed">30415446</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau E, Di Polo A, Vande Velde C, Robitaille R (2018) Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS. eLife 7. https://doi.org/10.7554/eLife.41973</Citation></Reference><Reference><Citation>Cozzolino M, Pesaresi MG, Gerbino V, Grosskreutz J, Carri MT (2012) Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention. Antioxid Redox Signal 17(9):1277&#x2013;1330. https://doi.org/10.1089/ars.2011.4328</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2011.4328</ArticleId><ArticleId IdType="pubmed">22413952</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377(2):162&#x2013;172. https://doi.org/10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Quattrone A, Morelli M, Nistico R, Manna I, Quattrone A (2020) Dropped head syndrome in a patient with FTD-ALS caused by abnormal expansion of C9orf72 gene. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 41(4):951&#x2013;952. https://doi.org/10.1007/s10072-019-04079-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04079-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L, Brunetti M, Di Pierro A, Barberis M, Croce R, Bersano E, De Marchi F, Zuccala M, Barizzone N, Calvo A, Moglia C, Mazzini L, Chio A, D'Alfonso S (2019) Analysis of the GCG repeat length in NIPA1 gene in C9orf72-mediated ALS in a large Italian ALS cohort. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 40(12):2537&#x2013;2540. https://doi.org/10.1007/s10072-019-04001-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04001-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, Getzoff ED, Hu P, Herzfeldt B, Roos RP, (1993) Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science (New York, NY) 261(5124):1047&#x2013;1051. https://doi.org/10.1126/science.8351519</Citation></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak&#x2013;Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59&#x2013;62. https://doi.org/10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, Pradat PF, Camu W, Meininger V, Dupre N, Rouleau GA (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40(5):572&#x2013;574. https://doi.org/10.1038/ng.132</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddique T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH Jr (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (New York, NY) 323(5918):1205&#x2013;1208. https://doi.org/10.1126/science.1166066</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539(7628):197&#x2013;206. https://doi.org/10.1038/nature20413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId><ArticleId IdType="pmc">5585017</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis E, Karampinis E, Siokas V, Aloizou AM, Rikos D, Ralli S, Papadimitriou D, Bogdanos DP, Hadjigeorgiou GM (2019) ERCC6L2 rs591486 polymorphism and risk for amyotrophic lateral sclerosis in Greek population. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 40(6):1237&#x2013;1244. https://doi.org/10.1007/s10072-019-03825-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03825-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning P, Yang X, Yang B, Zhao Q, Huang H, An R, Chen Y, Hu F, Xu Z, Xu Y (2018) Meta-analysis of the association between ZNF512B polymorphism rs2275294 and risk of amyotrophic lateral sclerosis. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 39(7):1261&#x2013;1266. https://doi.org/10.1007/s10072-018-3411-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3411-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F, Tiloca C, Morelli C, Doretti A, Poletti B, Maderna L, Messina S, Gentilini D, Fogh I, Ratti A, Silani V, Ticozzi N (2019) PON1 is a disease modifier gene in amyotrophic lateral sclerosis: association of the Q192R polymorphism with bulbar onset and reduced survival. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 40(7):1469&#x2013;1473. https://doi.org/10.1007/s10072-019-03834-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03834-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Jiang H, Wang F, Li S, Wu C, Bao J, Zhu Y, Xu Z, Liu B, Ren H, Yang X (2019) UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: a meta-analysis. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 40(11):2293&#x2013;2302. https://doi.org/10.1007/s10072-019-03951-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03951-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaus A, Sareen D (2015) ALS patient stem cells for unveiling disease signatures of motoneuron susceptibility: perspectives on the deadly mitochondria, ER stress and calcium triad. Front Cell Neurosci 9:448. https://doi.org/10.3389/fncel.2015.00448</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00448</ArticleId><ArticleId IdType="pubmed">26635528</ArticleId><ArticleId IdType="pmc">4652136</ArticleId></ArticleIdList></Reference><Reference><Citation>Contestabile A (2001) Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives. Curr Top Med Chem 1(6):553&#x2013;568. https://doi.org/10.2174/1568026013394723</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026013394723</ArticleId><ArticleId IdType="pubmed">11895131</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond L, Bernhardt K, Madria P, Sorrentino K, Scelsi H, Mitchell CS (2018) A metadata analysis of oxidative stress etiology in preclinical amyotrophic lateral sclerosis: benefits of antioxidant therapy. Front Neurosci 12:10. https://doi.org/10.3389/fnins.2018.00010</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00010</ArticleId><ArticleId IdType="pubmed">29416499</ArticleId><ArticleId IdType="pmc">5787557</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero MT, Morelli M (2017) Multiple mechanisms of neurodegeneration and progression. Prog Neurobiol 155:1. https://doi.org/10.1016/j.pneurobio.2017.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2017.06.001</ArticleId><ArticleId IdType="pubmed">28629600</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamati P, Siokas V, Aloizou AM, Karampinis E, Arseniou S, Rakitskii VN, Tsatsakis A, Spandidos DA, Gozes I, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E (2019) Does SCFD1 rs10139154 polymorphism decrease Alzheimer&#x2019;s disease risk? J Mol Neurosci 69(2):343&#x2013;350. https://doi.org/10.1007/s12031-019-01363-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-019-01363-3</ArticleId><ArticleId IdType="pubmed">31267315</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M, Filippini T, Violi F, Rothman KJ, Costanzini S, Malagoli C, Wise LA, Odone A, Signorelli C, Iacuzio L, Arcolin E, Mandrioli J, Fini N, Patti F, Lo Fermo S, Pietrini V, Teggi S, Ghermandi G, Scillieri R, Ledda C, Mauceri C, Sciacca S, Fiore M, Ferrante M (2017) Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis. Environ Health Glob Access Sci Source 16(1):91. https://doi.org/10.1186/s12940-017-0297-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12940-017-0297-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng E, Mao Y, Yao Q, Han X, Li X, Zhang K, Jin W (2020) Population-based study of environmental/occupational lead exposure and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 41(1):35&#x2013;40. https://doi.org/10.1007/s10072-019-04067-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04067-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh C, Hossain M, Solanki J, Dadas A, Marchi N, Janigro D (2016) Pathophysiological implications of neurovascular P450 in brain disorders. Drug Discov Today 21(10):1609&#x2013;1619. https://doi.org/10.1016/j.drudis.2016.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2016.06.004</ArticleId><ArticleId IdType="pubmed">27312874</ArticleId><ArticleId IdType="pmc">5067181</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutheil F, Beaune P, Loriot MA (2008) Xenobiotic metabolizing enzymes in the central nervous system: contribution of cytochrome P450 enzymes in normal and pathological human brain. Biochimie 90(3):426&#x2013;436. https://doi.org/10.1016/j.biochi.2007.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2007.10.007</ArticleId><ArticleId IdType="pubmed">17997991</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell G, Frost DO (1987) Target-controlled differentiation of axon terminals and synaptic organization. Proc Natl Acad Sci U S A 84(19):6929&#x2013;6933. https://doi.org/10.1073/pnas.84.19.6929</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.84.19.6929</ArticleId><ArticleId IdType="pubmed">2443913</ArticleId><ArticleId IdType="pmc">299198</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton DL, Gallagher EP, Bammler TK, Kunze KL (1995) Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics 5(5):259&#x2013;274. https://doi.org/10.1097/00008571-199510000-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00008571-199510000-00001</ArticleId><ArticleId IdType="pubmed">8563766</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen BB, Brix TH, Kyvik KO, Brosen K (2002) The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 12(6):473&#x2013;478. https://doi.org/10.1097/00008571-200208000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00008571-200208000-00008</ArticleId><ArticleId IdType="pubmed">12172216</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang YH, Lill CM, Lee PC, Hansen J, Lassen CF, Bertram L, Greene N, Sinsheimer JS, Ritz B (2016) Gene&#x2013;environment interaction in Parkinson&#x2019;s disease: coffee, ADORA2A, and CYP1A2. Neuroepidemiology 47(3&#x2013;4):192&#x2013;200. https://doi.org/10.1159/000450855</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000450855</ArticleId><ArticleId IdType="pubmed">28135712</ArticleId><ArticleId IdType="pmc">5465963</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L, Du Q, Jiang X, Wang L (2014) Effect of CYP1A2 polymorphism on the pharmacokinetics of agomelatine in Chinese healthy male volunteers. J Clin Pharm Ther 39(2):204&#x2013;209. https://doi.org/10.1111/jcpt.12118</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpt.12118</ArticleId><ArticleId IdType="pubmed">24372004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhang Z, Han S, Lu Y, Feng F, Yuan J (2012) CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case&#x2013;control studies. BMC Cancer 12:528. https://doi.org/10.1186/1471-2407-12-528</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2407-12-528</ArticleId><ArticleId IdType="pubmed">23157985</ArticleId><ArticleId IdType="pmc">3526566</ArticleId></ArticleIdList></Reference><Reference><Citation>Koonrungsesomboon N, Khatsri R, Wongchompoo P, Teekachunhatean S (2018) The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis. Pharmacogenomics J 18(6):760&#x2013;768. https://doi.org/10.1038/s41397-017-0011-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41397-017-0011-3</ArticleId><ArticleId IdType="pubmed">29282363</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, Shefner J (2015) A revision of the El Escorial criteria&#x2014;2015. Amyotroph Lateral Scler Frontotemporal Degener 16(5&#x2013;6):291&#x2013;292. https://doi.org/10.3109/21678421.2015.1049183</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Siokas V, Kardaras D, Aloizou AM, Asproudis I, Boboridis KG, Papageorgiou E, Hadjigeorgiou GM, Tsironi EE, Dardiotis E (2019) BDNF rs6265 (Val66Met) polymorphism as a risk factor for blepharospasm. NeuroMolecular Med 21(1):68&#x2013;74. https://doi.org/10.1007/s12017-018-8519-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-018-8519-5</ArticleId><ArticleId IdType="pubmed">30519954</ArticleId></ArticleIdList></Reference><Reference><Citation>Siokas V, Kardaras D, Aloizou AM, Asproudis I, Boboridis KG, Papageorgiou E, Spandidos DA, Tsatsakis A, Tsironi EE, Dardiotis E (2019) Lack of association of the rs11655081 ARSG gene with blepharospasm. J Mol Neurosci 67(3):472&#x2013;476. https://doi.org/10.1007/s12031-018-1255-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-018-1255-3</ArticleId><ArticleId IdType="pubmed">30656493</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis E, Siokas V, Zafeiridis T, Paterakis K, Tsivgoulis G, Dardioti M, Grigoriadis S, Simeonidou C, Deretzi G, Zintzaras E, Jagiella J, Hadjigeorgiou GM (2017) Integrins AV and B8 gene polymorphisms and risk for intracerebral hemorrhage in Greek and polish populations. NeuroMolecular Med 19(1):69&#x2013;80. https://doi.org/10.1007/s12017-016-8429-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-016-8429-3</ArticleId><ArticleId IdType="pubmed">27476161</ArticleId></ArticleIdList></Reference><Reference><Citation>Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38(2):209&#x2013;213. https://doi.org/10.1038/ng1706</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1706</ArticleId><ArticleId IdType="pubmed">16415888</ArticleId></ArticleIdList></Reference><Reference><Citation>Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics (Oxford, England) 22(15):1928&#x2013;1929. https://doi.org/10.1093/bioinformatics/btl268</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btl268</ArticleId></ArticleIdList></Reference><Reference><Citation>Siokas V, Aslanidou P, Aloizou AM, Peristeri E, Stamati P, Liampas I, Arseniou S, Drakoulis N, Aschner M, Tsatsakis A, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E (2020) Does the CD33 rs3865444 polymorphism confer susceptibility to Alzheimer&#x2019;s disease? J Mol Neurosci 70:851&#x2013;860. https://doi.org/10.1007/s12031-020-01507-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-020-01507-w</ArticleId><ArticleId IdType="pubmed">32088842</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunes A, Ozbey G, Vural EH, Uluoglu C, Scordo MG, Zengil H, Dahl ML (2009) Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population. Pharmacogenomics 10(5):769&#x2013;778. https://doi.org/10.2217/pgs.09.22</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/pgs.09.22</ArticleId><ArticleId IdType="pubmed">19450128</ArticleId></ArticleIdList></Reference><Reference><Citation>Popat RA, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, McGuire V, Costello S, Manthripragada AD, Southwick A, Myers RM, Nelson LM (2011) Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson&#x2019;s disease. Eur J Neurol 18(5):756&#x2013;765. https://doi.org/10.1111/j.1468-1331.2011.03353.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03353.x</ArticleId><ArticleId IdType="pubmed">21281405</ArticleId><ArticleId IdType="pmc">3556904</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachse C, Brockmoller J, Bauer S, Roots I (1999) Functional significance of a C--&gt;a polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47(4):445&#x2013;449. https://doi.org/10.1046/j.1365-2125.1999.00898.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2125.1999.00898.x</ArticleId><ArticleId IdType="pubmed">10233211</ArticleId><ArticleId IdType="pmc">2014233</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios N, Weisskopf M, Simon K, Gao X, Schwarzschild M, Ascherio A (2010) Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson&#x2019;s disease in men and women. Parkinsonism Relat Disord 16(6):370&#x2013;375. https://doi.org/10.1016/j.parkreldis.2010.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2010.02.012</ArticleId><ArticleId IdType="pubmed">20304699</ArticleId><ArticleId IdType="pmc">2916058</ArticleId></ArticleIdList></Reference><Reference><Citation>Siokas V, Kardaras D, Aloizou A-M, Liampas I, Papageorgiou E, Drakoulis N, Tsatsakis A, Mitsias PD, Hadjigeorgiou GM, Tsironi EE, Dardiotis E (2020) CYP1A2 rs762551 and ADORA2A rs5760423 polymorphisms in patients with blepharospasm. J Mol Neurosci. https://doi.org/10.1007/s12031-020-01553-4</Citation></Reference><Reference><Citation>Miksys SL, Tyndale RF (2002) Drug-metabolizing cytochrome P450s in the brain. J Psychiatry Neurosci 27(6):406&#x2013;415</Citation><ArticleIdList><ArticleId IdType="pubmed">12491573</ArticleId><ArticleId IdType="pmc">161713</ArticleId></ArticleIdList></Reference><Reference><Citation>Morse DC, Stein AP, Thomas PE, Lowndes HE (1998) Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain. Toxicol Appl Pharmacol 152(1):232&#x2013;239. https://doi.org/10.1006/taap.1998.8477</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/taap.1998.8477</ArticleId><ArticleId IdType="pubmed">9772218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghersi-Egea JF, Perrin R, Leininger-Muller B, Grassiot MC, Jeandel C, Floquet J, Cuny G, Siest G, Minn A (1993) Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol 45(3):647&#x2013;658. https://doi.org/10.1016/0006-2952(93)90139-n</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-2952(93)90139-n</ArticleId><ArticleId IdType="pubmed">8442765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentis A-FA, Pantelidi K, Dardiotis E, Hadjigeorgiou GM, Petinaki E (2018) Precision medicine and global health: the good, the bad, and the ugly. Front Med 5:67</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2018.00067</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentis A (2016) Epigenomic engineering for down syndrome. Neurosci Biobehav Rev 71:323&#x2013;327</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2016.09.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Belbasis L, Bellou V, Evangelou E (2016) Environmental risk factors and amyotrophic lateral sclerosis: an umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies. Neuroepidemiology 46(2):96&#x2013;105</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443146</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloizou AM, Siokas V, Vogiatzi C, Peristeri E, Docea AO, Petrakis D, Provatas A, Folia V, Chalkia C, Vinceti M, Wilks M, Izotov BN, Tsatsakis A, Bogdanos DP, Dardiotis E (2020) Pesticides, cognitive functions and dementia: a review. Toxicol Lett 326:31&#x2013;51. https://doi.org/10.1016/j.toxlet.2020.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2020.03.005</ArticleId><ArticleId IdType="pubmed">32145396</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis E, Siokas V, Sokratous M, Tsouris Z, Aloizou AM, Florou D, Dastamani M, Mentis AA, Brotis AG (2018) Body mass index and survival from amyotrophic lateral sclerosis: a meta-analysis. Neurol Clin Pract 8(5):437&#x2013;444. https://doi.org/10.1212/cpj.0000000000000521</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/cpj.0000000000000521</ArticleId><ArticleId IdType="pubmed">30564498</ArticleId><ArticleId IdType="pmc">6276330</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>